Laxmi Organic Industries Ltd - 543277 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we wish to inform you that the Company participated in the investor conference as enclosed. Laxmi Organic Industries Ltd - 543277 - Intimation Of Statement Of Deviation And Variation Under Regulation 32(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that there has been no deviation in the utilization of IPO Proceeds from the objects stated in the prospectus dated March 18, 2021. In this regard, please see enclosed statement of deviation and variation for the quarter and year ended March 31, 2022. We request you to take the above on record. Laxmi Organic Industries Ltd - 543277 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby confirm that there has been no deviation in the utilization of IPO Proceeds from the objects stated in the prospectus dated March 18, 2021. In this regard, please see enclosed Monitoring Agency Report issued by Axis Bank Limited (Monitoring Agent) for the quarter and year ended March 31, 2022. We request you to take the above on record. Laxmi Organic Industries Ltd - 543277 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to regulation 30 and 47 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please see enclosed published newspaper advertisement of the standalone and consolidated financial results of the Company for the quarter and year ended March 31, 2022. We request you to take the above on record.
Earnings Call for Q4FY22 of Laxmi Organic Industries
Conference Call with Laxmi Organic Industries Management and Analysts on Q4FY22 Performance and Outlook. Listen to the full earnings transcript. Q4FY22 Quarterly Result Announced for Laxmi Organic Industries Ltd.
Specialty Chemicals firm Laxmi Organic Industries declares Q4FY22 result: FY22 Standalone Operating Revenue of Rs 29,965 Mn. Q4 FY22 Standalone Operating Revenue of Rs 9,062 Mn. FY22 Profit After Tax at Rs 2,311 Mn; Q4 FY22 Profit After Tax at Rs 410 Mn Standalone Financial Highlights for the Year Ended March 31 st, 2022: Operating Revenues at Rs 29,965 Mn in FY22 as compared to Rs 16,061 Mn in FY21; a growth of 87% YoY EBITDA at Rs 3,194 Mn in FY22 as compared to Rs 2,025 Mn in FY21; a growth of 58% YoY EBITDA Margins stood at 11% in FY22, as compared to 13% in FY21 Profit After Tax at Rs 2,311 Mn in FY22 as compared to Rs 1,226 Mn in FY21; a growth of 89% YoY EPS for FY22 was 8.77 as compared to 5.40 in FY21 Standalone Financial Highlights for Quarter Ended March 31st, 2022: Operating Revenues at Rs 9,062 Mn in Q4FY22 as compared to Rs 4,674 Mn in Q4FY21; a growth of 94% YoY and growth of 4% QoQ EBITDA at Rs 568 Mn in Q4 FY22 as compared to Rs 556 Mn in Q4 FY21; a growth of 2% YoY, de-growth of 44% QoQ EBITDA margin stood at 6% in Q4 FY22 and contracted by 564 bps YoY and by 539 bps QoQ Profit After Tax at Rs 410 Mn in Q4 FY22 as compared to Rs 312 Mn in Q4 FY21; a growth of 31% YoY and contraction of 49% QoQ EPS for Q4FY22 was 1.56 as compared to 1.34 in Q4FY21 Consolidated Financial Highlights for Year Ended March 31st, 2022: Operating Revenues at Rs 30,842 Mn in FY22 as compared to Rs 17,684 Mn in FY21; a growth of 74% YoY EBITDA at Rs 3,677 Mn in FY22 as compared to Rs 2,167 Mn in FY21; a growth of 70% YoY EBITDA Margins stood at 12% in FY22, in line with same period last year Profit After Tax at Rs 2,565 Mn in FY22 as compared to Rs 1,271 Mn in FY21; a growth of 102% YoY EPS for FY22 was 9.72 as compared to 5.58 in FY21 Consolidated Financial Highlights for Quarter Ended March 31st, 2022: Operating Revenues at Rs 8,799 Mn in Q4FY22 as compared to Rs 5,195 Mn in Q4FY21; a growth of 69% YoY and of 2% QoQ EBITDA at Rs 730 Mn in Q4FY22 as compared to Rs 655 Mn in Q4FY21; a growth of 11% YoY and a de-growth of 39% QoQ EBITDA Margins stood at 8% in Q4FY22; contracted by 431 bps YoY and by 551 bps QoQ Profit After Tax at Rs 575 Mn in Q4FY22 as compared to Rs 364 Mn in Q4FY21; a growth of 58% YoY and a de-growth of 30% QoQ EPS for Q4FY22 was 2.30 as compared to 1.56 in Q4FY21 Commenting on the strong financial performance Mr. Ravi Goenka, Chairman & Managing Director, said, “I am happy to share that FY 22 has been a strong year despite the headwinds that we faced on many fronts. We recorded a strong performance in both our business segments – Acetyl Intermediates (AI) and Specialty Intermediates (SI), despite the Mahad plant being shut for 50 days between July and August 2021 on account of floods. This was also compounded by high volatility in raw material costs along with logistical challenges. However, our results this year highlight the true merits and strength of our business. Our performance this quarter was largely driven by our SI business, which performed strongly on both fronts - volume and product mix. The volumes in this quarter which mirrored what we did in the last quarter saw a richer product mix. We made an entry into US which is a new market that opened for this in this quarter. Our SI revenue grew by 74% on annual basis and 5% on a sequential basis from Q3FY22. On the AI front, this quarter, while our volumes remain strong, margins were impacted due to price corrections. Our pricing in Europe for the AI segment remained robust, and it is expected to remain so in the near future as well. AI revenue grew by 98% in FY22 from FY21, and on a quarterly basis by around 1% from Q3FY22. I am happy to share that we have successfully brought into stream part of our SI Capex, the commercial production of which has started in Q1FY23, and the rest shall begin by Q3FY23. Our FI Capex, which is being undertaken in a phased manner, remains on track and is expected to be completed by Q3FY23. Going forward, we will continue to drive operational efficiencies and maintain our leadership position in AI, through enhanced capacities and periodic debottlenecking. For our SI segment, we are confident that new capacities will further improve our product mix, while we focus on increasing the share of contractual sales and expand geographical presence. The opportunity in our FI segment is robust, we are preparing for a phased growth beginning with agrochemicals and progressing to pharmaceuticals and industrials later. The strategy of creating a strong foundation has worked for us in our SI segment, and we are confident that we can replicate that success in our FI area as well.” Result PDF Laxmi Organic Industries Ltd - 543277 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company had informed that it will hold Investor & Analyst Meet to discuss performance for the quarter and year ended March 31, 2022, on Thursday, May 05, 2022, at 15:00 hours (IST). In this regard, please see enclosed investors presentation for the aforementioned meet. Further, we have also enclosed press release for the quarter and year ended March 31, 2022. We request you to take this intimation on record. Laxmi Organic Industries Ltd - 543277 - Board recommends Final Dividend
Laxmi Organic Industries Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 04, 2022, inter alia, has recommended final dividend of Rs. 0.70/- per share of the face value of Rs. 2/- each (i.e. 35% of the face value) which is subject to approval by the Members of the Company at the forthcoming 33rd Annual General Meeting. Laxmi Organic Industries Ltd - 543277 - Grant Of Employee Stock Options As Per Laxmi - Employee Stock Option Plan 2020 ('ESOP-2020')
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Nomination and Remuneration Committee of the Board of Directors of the Company at its meeting held on Wednesday, May 04, 2022, has approved grant of Stock options under Laxmi - Employee Stock Option Plan 2020 ('ESOP-2020') as per details mentioned in the enclosed letter.